<prompt> Please answer with one of the option in the bracket. Write reasoning in between . Write answer in between .Q:A 62-year-old woman presents to the clinic with a lacerated wound on her left forearm. She got the wound accidentally when she slipped in her garden and scraped her hand against some nails sticking out of the fence. The patient has rheumatoid arthritis and takes methylprednisolone 16 mgday. She cannot recall her vaccination history. On physical examination her blood pressure is 14095 mm Hg, heart rate is 81min, respiratory rate is 16min, and temperature is 36.9C 98.4F. The wound is irregularly shaped and lacerated and measures 4 × 5 cm with a depth of 0.5 cm. It is contaminated with dirt. The physician decides to administer both the tetanus toxoid and immunoglobulin after wound treatment. What is true regarding the tetanus prophylaxis in this patient?? A: It does not make sense to administer tetanus toxoid as it will fail to induce sufficient immunity in a patient who takes oral glucocorticoids., B: The immunoglobulin is given to this patient to promote the action of the toxoid and antibody production., C: The immunoglobulin administration will provide sufficient levels of anti-tetanus toxin antibodies until the production of the patients own antibodies starts., D: It does not make sense to administer tetanus toxoid as it will fail to induce sufficient immunity in patients aged more than 60 years., E: Immunoglobulin administration can provide constant levels of antibodies in the patients blood for more than 4 months.,  <response>: This is a question about tetanus prophylaxis in a 62-year-old woman with a contaminated wound who is taking oral glucocorticoids. The key points are:- Patient is 62 years old - Has a contaminated wound, so she is at risk of tetanus infection- Is taking oral glucocorticoids methylprednisolone which may inhibit immune response to vaccines- Vaccination history is unknownThe question is asking what is true about administering both tetanus toxoid vaccine and tetanus immunoglobulin in this patient.C: The immunoglobulin administration will provide sufficient levels of anti-tetanus toxin antibodies until the production of the patients own antibodies starts. 